BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9554245)

  • 1. Oral contraceptive use and benign gynecologic conditions. A review.
    Chiaffarino F; Parazzini F; La Vecchia C; Ricci E; Crosignani PG
    Contraception; 1998 Jan; 57(1):11-8. PubMed ID: 9554245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive type and functional ovarian cysts.
    Lanes SF; Birmann B; Walker AM; Singer S
    Am J Obstet Gynecol; 1992 Mar; 166(3):956-61. PubMed ID: 1550172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncontraceptive health benefits of oral steroidal contraceptives.
    Mishell DR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral contraceptives and uterine fibroids: results from a case-control study.
    Chiaffarino F; Parazzini F; La Vecchia C; Marsico S; Surace M; Ricci E
    Br J Obstet Gynaecol; 1999 Aug; 106(8):857-60. PubMed ID: 10453838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.
    Contracept Rep; 1994 Mar; 5(1):6-9. PubMed ID: 12287739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive methods and risk of pelvic endometriosis.
    Parazzini F; Ferraroni M; Bocciolone L; Tozzi L; Rubessa S; La Vecchia C
    Contraception; 1994 Jan; 49(1):47-55. PubMed ID: 8137625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disease and contraception. Recent aspects].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
    Schlesselman JJ
    Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive use and myocardial infarction.
    Petitti DB; Sidney S; Quesenberry CP
    Contraception; 1998 Mar; 57(3):143-55. PubMed ID: 9617531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1995 pill scare revisited: anatomy of a non-epidemic.
    Spitzer WO
    Hum Reprod; 1997 Nov; 12(11):2347-57. PubMed ID: 9436662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined oral contraceptives: risks and benefits.
    Thorogood M; Villard-Mackintosh L
    Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and cancer. A review of the evidence.
    La Vecchia C; Tavani A; Franceschi S; Parazzini F
    Drug Saf; 1996 Apr; 14(4):260-72. PubMed ID: 8713694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.